NorthWest Biotherapeutics Inc (NWBO): Fat Cat, I believe the DMC will recommen...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	12
Posts	2176
Boards Moderated	0
Alias Born	03/17/2010

ou71764

Re: FatCat_Banker post# 3605

Friday, 01/24/2014 12:17:07 PM

Friday, January 24, 2014 12:17:07 PM

Fat Cat, I believe the DMC will recommend that the DCVax-L trial "continue" as originally planned.

I have pushed Flipper and gpb to give their reasons for believing the recommendation will be to halt the trial due to efficacy, or at least to get their odds for it happening. It isn't because I want to debate anyone on it - quite the opposite, it's because I want to think we have a real chance at it. But a continue is the most likely IMO.

DCVax-Direct is the other vaccine in the pipeline, for inoperable solid tumors. It could be even bigger if successful. DCVax-prostate is on hold, awaiting a partner for phase III.

So all the company has is a series of DCVax vaccines - and it's enough! The vaccines can be improved over time and get new patents, extending their value to the company for decades.